Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (17)

« Back to Publications

Glycoprotein non-metastatic melanoma protein B is a biomarker of inflammation in individuals with Gaucher disease: relationship to clinico-pathological subtypes.

Kilavuz S. et al, (2025), Orphanet J Rare Dis, 20

Dysregulation of the NLRP3 Inflammasome and Promotion of Disease by IL-1β in a Murine Model of Sandhoff Disease.

Platt N. et al, (2025), Cells, 14

Cholera intoxication of human enteroids reveals interplay between decoy and functional glycoconjugate ligands.

Singla A. et al, (2023), Glycobiology, 33, 801 - 816

Glycosphingolipid Changes in Plasma in Parkinson's Disease Independent of Glucosylceramide Levels.

Te Vruchte D. et al, (2022), Mov Disord, 37, 2129 - 2134

Glycosphingolipid metabolism and its role in ageing and Parkinson's disease.

Wallom K-L. et al, (2022), Glycoconj J, 39, 39 - 53

Transcriptome of HPβCD-treated Niemann-Pick disease type C1 cells highlights GPNMB as a biomarker for therapeutics.

Rodriguez-Gil JL. et al, (2021), Hum Mol Genet, 30, 2456 - 2468

Systemic AAV9 gene therapy using the synapsin I promoter rescues a mouse model of neuronopathic Gaucher disease but with limited cross-correction potential to astrocytes.

Massaro G. et al, (2020), Hum Mol Genet, 29, 1933 - 1949

GM1 ganglioside-independent intoxication by Cholera toxin.

Cervin J. et al, (2018), PLoS Pathog, 14

Heat shock protein-based therapy as a potential candidate for treating the sphingolipidoses.

Kirkegaard T. et al, (2016), Sci Transl Med, 8

Immune dysfunction in Niemann-Pick disease type C.

Platt N. et al, (2016), J Neurochem, 136 Suppl 1, 74 - 80

Measuring relative lysosomal volume for monitoring lysosomal storage diseases.

te Vruchte D. et al, (2015), Methods Cell Biol, 126, 331 - 347

Improved neuroprotection using miglustat, curcumin and ibuprofen as a triple combination therapy in Niemann-Pick disease type C1 mice.

Williams IM. et al, (2014), Neurobiol Dis, 67, 9 - 17

Relative acidic compartment volume as a lysosomal storage disorder-associated biomarker.

te Vruchte D. et al, (2014), J Clin Invest, 124, 1320 - 1328

Impact of polymer tacticity on the physico-chemical behaviour of polymers proposed as therapeutics.

Izzo L. et al, (2011), Int J Pharm, 408, 213 - 222

Beneficial effects of anti-inflammatory therapy in a mouse model of Niemann-Pick disease type C1.

Smith D. et al, (2009), Neurobiol Dis, 36, 242 - 251

Load More